Correction: Corrigendum: The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors

被引：0

作者：

Alex Berndt

Simon Miller

Olusegun Williams

Daniel D Le

Benjamin T Houseman

Joseph I Pacold

Fabrice Gorrec

Wai-Ching Hon

Pingda Ren

Yi Liu

Christian Rommel

Pascale Gaillard

Thomas Rückle

Matthias K Schwarz

Kevan M Shokat

Jeffrey P Shaw

Roger L Williams

机构：

来源：

Nature Chemical Biology | 2010年 / 6卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Nat. Chem. Biol. 6, 117–124 (2010); published online 10 January 2010; corrected after print 12 February 2010 In the version of this article initially published, Pingda Ren was inadvertently left off the author list. The error has been corrected in the author list, author contributions and conflict of financial interest declaration of the HTML and PDF versions of the article.

引用

页码：244 / 244

共 50 条

[21] Enhanced PI3K p110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110α-Selective PI3K Inhibitor
Brady, Samuel W.
Zhang, Jian
Seok, Daniel
Wang, Hai
Yu, Dihua
[J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 60 - 70
[22] Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors
Kendall, Jackie D.
Rewcastle, Gordon W.
Frederick, Raphael
Mawson, Claire
Denny, William A.
Marshall, Elaine S.
Baguley, Bruce C.
Chaussade, Claire
Jackson, Shaun P.
Shepherd, Peter R.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7677 - 7687
[23] Human tumor mutants in the p110α subunit of PI3K
Liu, Zhenning
Roberts, Thomas M.
[J]. CELL CYCLE, 2006, 5 (07) : 675 - 677
[24] p110 δ PI3K as a therapeutic target of solid tumours
Xenou, Lydia
Papakonstanti, Evangelia A.
[J]. CLINICAL SCIENCE, 2020, 134 (12) : 1377 - 1397
[25] Discovery of benzoxazepin PI3K inhibitors and optimization of p110-alpha selectivity
Ndubaku, Chudi O.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[26] The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation
Beer-Hammer, Sandra
Zebedin, Eva
von Holleben, Max
Alferink, Judith
Reis, Bernhard
Dresing, Philipp
Degrandi, Daniel
Scheu, Stefanie
Hirsch, Emilio
Sexl, Veronika
Pfeffer, Klaus
Nuernberg, Bernd
Piekorz, Roland P.
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (06) : 1083 - 1095
[27] Non-redundant involvement of the PI3K isoforms p110γ and p110δ in the development and survival of myeloid cells
Bucher, Kirsten
Schmitt, Fee
Autenrieth, Stella
Nuernberg, Bernd
Beer-Hammer, Sandra
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S32 - S32
[28] The PI3Ks p110α and p110δ control regulatory T cell function
Slack, E. C. M.
Soond, D. R.
Scudamore, C. L.
Garden, O. A.
Okkenhaug, K.
[J]. IMMUNOLOGY, 2011, 135 : 54 - 54
[29] Dominant Role of the p110β Isoform of PI3K over p110α in Energy Homeostasis Regulation by POMC and AgRP Neurons
Al-Qassab, Hind
Smith, Mark A.
Irvine, Elaine E.
Guillermet-Guibert, Julie
Claret, Marc
Choudhury, Agharul I.
Selman, Colin
Piipari, Kaisa
Clements, Melanie
Lingard, Steven
Chandarana, Keval
Bell, Jimmy D.
Barsh, Gregory S.
Smith, Andrew J. H.
Batterham, Rachel L.
Ashford, Michael L. J.
Vanhaesebroeck, Bart
Withers, Dominic J.
[J]. CELL METABOLISM, 2009, 10 (05) : 343 - 354
[30] PI 3-kinase p110β:: a new target for antithrombotic therapy
Jackson, SP
Schoenwaelder, SM
Goncalves, I
Nesbitt, WS
Yap, CL
Wright, CE
Kenche, V
Anderson, KE
Dopheide, SM
Yuan, YP
Sturgeon, SA
Prabaharan, H
Thompson, PE
Smith, GD
Shepherd, PR
Daniele, N
Kulkarni, S
Abbott, B
Saylik, D
Jones, C
Lu, L
Giuliano, S
Hughan, SC
Angus, JA
Robertson, AD
Salem, HH
[J]. NATURE MEDICINE, 2005, 11 (05) : 507 - 514

← 1 2 3 4 5 →